Home QuantumPharm Successfully Lists on HKEX Main Board, Pioneering AI-Driven Drug Discovery and Materials Innovation

QuantumPharm Successfully Lists on HKEX Main Board, Pioneering AI-Driven Drug Discovery and Materials Innovation

Jun 13, 2024 15:43 CST Updated 15:43
XtalPi

Computation-Driven Innovative Drug R&D Provider

36Kr learned that XtalPi successfully listed on the Main Board of the Hong Kong Stock Exchange today. According to reports, XtalPi is a technology company driven by artificial intelligence and robotics innovation, providing innovative technologies, services, and products for industries such as biomedicine, chemicals, new energy, and new materials. Previously, XtalPi received investments from ZhenFund, 5Y Capital, Tencent, Google, and other institutions and companies.Original Link